Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07818681

Predictors of Postnatal Growth Failure in Preterm Infants

This prospective observational study aims to identify the clinical and nutritional predictors of postnatal growth failure among preterm infants admitted to the Neonatal Intensive Care Unit of Assiut University Children's Hospital.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

About this study

Postnatal growth failure is a common complication among preterm infants admitted to neonatal intensive care units. This prospective cohort study will include preterm infants (gestational age less than 37 weeks) admitted to the NICU within the first 24 hours of life and hospitalized for at least 14 days.

Clinical data, nutritional practices, and serial anthropometric measurements will be collected from admission until hospital discharge. Postnatal growth failure will be defined as a discharge weight below the 10th percentile for postmenstrual age according to the Fenton Growth Chart and/or a decline in weight Z-score of more than 1.0 standard deviation between birth and discharge. The study will identify independent clinical and nutritional predictors of postnatal growth failure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Gestational age less than 37 completed weeks
  • Admission to the NICU within the first 24 hours after birth
  • Hospitalization for at least 14 days
  • Availability of complete clinical, nutritional, and anthropometric data
  • Written informed consent from parents or legal guardians

Exclusion criteria

  • - Major congenital malformations
  • Chromosomal abnormalities
  • Major congenital gastrointestinal anomalies interfering with feeding
  • Major congenital heart diseases requiring early surgical intervention
  • Inborn errors of metabolism
  • Congenital TORCH infections

Treatment and study plan

Primary outcomes

  1. Occurrence of postnatal growth failure

    Time frame: Up to 30 days

    Proportion of preterm infants who develop postnatal growth failure at hospital discharge, defined as discharge weight below the 10th percentile for postmenstrual age according to the Fenton Growth Chart, or a decline in weight-for-age Z-score of more than 1.0 standard deviation between birth and discharge.

Secondary outcomes

  1. Growth velocity

    Time frame: Up to 30 days

    Growth velocity expressed as grams per kilogram per day (g/kg/day) during hospitalization

  2. Time to achieve full enteral feeding

    Time frame: Up to 30 days

    Number of days from birth to achievement of full enteral feeding (150 mL/kg/day).

  3. Duration of parenteral nutrition

    Time frame: Up to 30 days

    Number of days of parenteral nutrition during hospitalization.

  4. Length of hospital stay

    Time frame: Up to 30 days

    Duration of hospitalization in days.

  5. In-hospital mortality

    Time frame: Up to 30 days

    Rate of mortality during the NICU stay.

Study contacts

Contact information is provided by the study sponsor or research team.

Kamal G Ahmed, Resident

CONTACT

[email protected]

+20 11 41620746

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Clinical and Nutritional Predictors of Postnatal Growth Failure in Preterm Infants Admitted to the Neonatal Intensive Care Unit of Assiut University Children's Hospital

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Sep 14, 2026
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.